ImportRefusal LogoImportRefusal

SHAANXI PULIZHONGHE BIOPHARMACEUTIC

⚠️ High Risk

FEI: 3037858925 • Qinhan New City • CHINA

FEI

FEI Number

3037858925

📍

Location

Qinhan New City

🇨🇳

Country

CHINA
🏢

Address

No 12 Zone C Qinhan Health, Technology Industrial Park Zhengyang Street Office, Qinhan New City, , China

High Risk

FDA Import Risk Assessment

54.9
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

1
Total Refusals
1
Unique Violations
6/3/2025
Latest Refusal
6/3/2025
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
11.2×30%
Recency
72.9×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
6/3/2025
66VAM99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is SHAANXI PULIZHONGHE BIOPHARMACEUTIC's FDA import refusal history?

SHAANXI PULIZHONGHE BIOPHARMACEUTIC (FEI: 3037858925) has 1 FDA import refusal record(s) in our database, spanning from 6/3/2025 to 6/3/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. SHAANXI PULIZHONGHE BIOPHARMACEUTIC's FEI number is 3037858925.

What types of violations has SHAANXI PULIZHONGHE BIOPHARMACEUTIC received?

SHAANXI PULIZHONGHE BIOPHARMACEUTIC has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about SHAANXI PULIZHONGHE BIOPHARMACEUTIC come from?

All FDA import refusal data for SHAANXI PULIZHONGHE BIOPHARMACEUTIC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.